FATE insider transaction filings
FATE THERAPEUTICS INC — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-05. Screen FATE transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings by 2 insiders — 82,747 shares, $203,506 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 43,947 shares @ $2.46 ($108,101) by Valamehr Bahram, filed 2026-08-05.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Valamehr Bahram — President and CEO, Director | 1 | — | 1 leg · 43,947 sh · $108,101 | — |
| TAHL CINDY — See Remarks | 1 | — | 1 leg · 38,800 sh · $95,405 | — |
Recent Form 4 filings — FATE THERAPEUTICS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | TAHL CINDY — See Remarks | Sale (S): 38,800 @ $2.46 | EDGAR |
| 2026-08-05 | 4 | Valamehr Bahram — President and CEO, Director | Sale (S): 43,947 @ $2.46 | EDGAR |
| 2026-06-15 | 4 | Xu Yuan — Director | Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Jooss Karin — Director | Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Agarwal Shefali — Director | Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | ABERNETHY MATT — Director | Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Hamill Laura — Director | Grant/award (A): 175,800 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Lee Michael Stewart — Director | Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Redmile Group, LLC — Director, 10% owner Green Jeremy — Director, 10% owner | Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | EPSTEIN ROBERT S — Director | Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | TAHL CINDY — See Remarks | Sale (S): 25,590 @ $1.88 | EDGAR |
| 2026-05-21 | 4 | Valamehr Bahram — President and CEO, Director | Sale (S): 28,946 @ $1.88 | EDGAR |
| 2026-05-07 | 4 | TAHL CINDY — See Remarks | Option exercise (M): 122,220 @ $1.32 · Option exercise (M): 44,444 @ $1.05 · Option exercise (M): 122,220 (derivative) @ $0 · Option exercise (M): 44,444 (derivative) @ $0 | EDGAR |
| 2026-05-06 | 4 | EPSTEIN ROBERT S — Director | Option exercise (M): 25,000 @ $1.69 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-05-06 | 4 | RASTETTER WILLIAM H — Director | Option exercise (M): 25,000 @ $1.69 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4/A | Redmile Group, LLC — Director, 10% owner Green Jeremy — Director, 10% owner RedCo II Master Fund, L.P. — Director, 10% owner | Other (J): 266,280 (derivative) @ $0 · Other (J): 266,280 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Redmile Group, LLC — Director, 10% owner Green Jeremy — Director, 10% owner RedCo II Master Fund, L.P. — Director, 10% owner | Other (J): 8,977,624 @ $0 · Other (J): 8,977,624 @ $0 · Other (J): 3,691,324 (derivative) @ $0 · Other (J): 3,691,324 (derivative) @ $0 · Other (J): 266,280 (derivative) @ $0 · Other (J): 266,280 (derivative) @ $0 · +2 more | EDGAR |
| 2026-01-16 | 4 | TAHL CINDY — See Remarks | Grant/award (A): 100,000 @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Adawi Kamal — Chief Financial Officer | Grant/award (A): 25,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Valamehr Bahram — President and CEO, Director | Grant/award (A): 335,000 @ $0 · Grant/award (A): 1,300,000 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | TAHL CINDY — See Remarks | Sale (S): 10,589 @ $1.06 | EDGAR |
| 2026-01-12 | 4 | Valamehr Bahram — President and CEO, Director | Sale (S): 5,190 @ $1.07 | EDGAR |
| 2025-10-21 | 4 | Adawi Kamal — Chief Financial Officer | Grant/award (A): 75,000 @ $0 · Grant/award (A): 375,000 (derivative) @ $0 | EDGAR |
| 2025-08-05 | 4 | TAHL CINDY — See Remarks | Sale (S): 9,037 @ $1.06 | EDGAR |
| 2025-08-05 | 4 | Valamehr Bahram — President and CEO, Director | Sale (S): 14,466 @ $1.06 | EDGAR |
| 2025-05-30 | 4 | Lee Michael Stewart — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Xu Yuan — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Mozaffarian Neelufar — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Jooss Karin — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | ABERNETHY MATT — Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Agarwal Shefali — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Redmile Group, LLC — Director, 10% owner Green Jeremy — Director, 10% owner | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | EPSTEIN ROBERT S — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | MENDLEIN JOHN — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-01-16 | 4 | Valamehr Bahram — President and CEO, Director | Grant/award (A): 1,300,000 (derivative) @ $0 | EDGAR |
| 2025-01-16 | 4 | TAHL CINDY — See Remarks | Grant/award (A): 70,000 @ $0 · Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2025-01-16 | 4 | Bressi Jerome Charles — See Remarks | Grant/award (A): 65,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | Bressi Jerome Charles — See Remarks | Sale (S): 5,980 @ $1.55 | EDGAR |
| 2025-01-13 | 4 | TAHL CINDY — See Remarks | Sale (S): 5,654 @ $1.55 | EDGAR |
| 2025-01-13 | 4 | Valamehr Bahram — President and CEO, Director | Sale (S): 8,705 @ $1.54 | EDGAR |
| 2024-12-26 | 4 | Redmile Group, LLC — Director, 10% owner Green Jeremy — Director, 10% owner | Other (J): 1,084,936 @ $1.68 · Other (J): 1,084,936 @ $1.68 · Sale (S): 341,633 @ $1.68 · Purchase (P): 397,964 @ $1.68 · Other (J): 116,261 (derivative) @ $8.40 · Other (J): 116,261 (derivative) @ $8.40 · +1 more | EDGAR |
| 2024-12-16 | 4 | Redmile Group, LLC — Director, 10% owner Green Jeremy — Director, 10% owner | Conversion (C): 30,110 · Conversion (C): 6,022 (derivative) | EDGAR |
| 2024-08-07 | 4 | Xu Yuan — Director | Sale (S): 633 @ $4.23 | EDGAR |
| 2024-07-31 | 4 | Valamehr Bahram — Chief R&D Officer | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2024-07-31 | 4 | Mozaffarian Neelufar — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2024-07-31 | 4 | TAHL CINDY — General Counsel and Secretary | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2024-06-11 | 4 | MENDLEIN JOHN — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — FATE THERAPEUTICS INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-27 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-17 | 8-K/A | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FATE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →